Affix Labs raises €1m for European distribution and B2B expansion
VP Capital and Oost NL lead financing for Repeltec’s rollout and the company’s white-label offering.
Financing and next steps
The April announcement sets out distribution expansion in Germany, Austria, France and Norway, with the UK and Poland planned next.
Affix is also launching “Powered by Affix Labs,” allowing FMCG, hospitality and pest-control businesses to integrate its formulations into their own ranges. The financing supports commercial expansion around an existing product, rather than announcing the completion of every planned market launch.